Skip to main content
. 2021 Mar 6;18(5):2654. doi: 10.3390/ijerph18052654

Table 5.

Related Samples Wilcoxon Signed-Rank test pre-and post-therapy.

Experimental Group Control Group
Pre-Therapy Post-Therapy Pre-Therapy Post-Therapy
Median
(IR)
Median
(IR)
p Cohen’s d Median
(IR)
Median
(IR)
p Cohen’s d
ROM (mean) 39.17 (5.42) 42.92 (7.42) <0.001 0.645 37.71 (7.40) 38.83 (8.56) <0.001 0.504
MMT (mean) 2.89 (1.02) 3.05 (0.81) <0.001 0.533 2.86 (0.73) 3.07 (0.81) <0.001 0.324
MAS 2.00 (2.00) 2.00 (2.00) 0.157 −0.049 1.00 (1.00) 1.00 (1.00) 1.000 0.00
MRS 2.00 (1.00) 2.00 (1.00) 1.000 0.00 2.00 (0.75) 2.00 (0.75) 1.000 0
Motor FMLE 24.00 (6.00) 27.00 (7.00) 0.000 0.685 24.50(6.75) 25.5 (6.50) 0.000 0.254
Passive FMLE 17.00 (5.00) 20.00 (2.00) 0.136 0.466 17.50 (3.75) 18.00 (3.75) 0.034 0.121
Pain FMLE 20.00 (0.00) 20.00 (0.00) 0.020 0.212 20.00 (4.50) 20.00 (3.00) 0.063 0.157
FIM 114.00 (13.00) 114.00 (13.00) 1.000 0 121.00 (15.75) 121.00 (15.75) 0.157 0.010
TUG 2.00 (0.00) 2.00 (1.00) 0.083 0.011 2.00 (0.00) 2.00 (0.00) 0.317 0.075
FRT 25.00 (8.00) 27.00 (5.30) 0.000 0.573 23.00 (11.00) 23.00 (12.75) 0.470 0.004

IR—Interquartile, Range ROM—Range of Motion, MMT—Manual Muscle Testing, FMLE: Fugl-Meyer Assessment for Lower Extremity; MRS: Modified Rankin Scale, FIM: Functional Independence Measure; MAS: Modified Ashworth Scale; TUG—Timed Up and Go test FRT: Functional Reach Test.